Overview

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Status:
Completed
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of Escitalopram in the treatment of obsessive compulsive disorder and to determine the optimal treatment dose.
Phase:
Phase 4
Details
Lead Sponsor:
Massachusetts General Hospital
Collaborator:
Forest Laboratories
Treatments:
Citalopram
Dexetimide